Browsing Tag
Prognosis Elevate
1 post
Integrated Research (ASX: IRI) revenue drops as Iris and Prognosis Elevate face FY2027 monetisation test
Integrated Research’s cash balance is now close to its entire ASX market value, but weaker renewals and negative EBITDA show why investors remain cautious.